Literature DB >> 25684733

Designer steroids - over-the-counter supplements and their androgenic component: review of an increasing problem.

C D Rahnema1, L E Crosnoe, E D Kim.   

Abstract

Colloquially referred to by various misleading monikers ('pro-hormones', 'natural steroids', 'testosterone boosters', etc.) designer anabolic steroids have been popular now for over a decade as a way to achieve classic anabolic steroid-like results from products sold in the legal marketplace. Recent evidence suggests that anabolic steroid use may be the most common cause of hypogonadism in men of reproductive age. Despite recent regulatory efforts that have banned specific compounds, many anabolic-androgenic steroids (AAS) remain available in over-the-counter dietary supplements that are legally sold in the United States. Severe side effects including hepatotoxicity, cholestasis, renal failure, hypogonadism, gynecomastia, and infertility have been reported secondary to the use of these products. While some of these side effects may be reversible, more aggressive use may result in more permanent end-organ damage as has been previously described for the case of aggressive AAS users (Rahnema et al., Fertil Steril, 2014). Designer AAS remain easily available for purchase in over-the-counter bodybuilding supplements and these products appear to be increasingly popular, despite the known health risks associated with their use. We conducted a systematic search to identify the designer steroids that are most commonly sold in dietary supplements as of April 2014 and review what is known regarding their potency and toxicity. We propose that the impact of AAS use on the reproductive and hormonal health of men is underestimated in the literature owing to previous studies' failure to account for designer steroid use. Lastly, we make clinical recommendations to help physicians steer patients away from potentially harmful supplements, and summarize key regulatory obstacles that have allowed potent androgens to remain unregulated in the legal marketplace.
© 2015 American Society of Andrology and European Academy of Andrology.

Entities:  

Keywords:  anabolic steroid-induced hypogonadism; designer steroids; dietary supplements; dimethazine; mentabolan; methylstenbolone

Mesh:

Substances:

Year:  2015        PMID: 25684733     DOI: 10.1111/andr.307

Source DB:  PubMed          Journal:  Andrology        ISSN: 2047-2919            Impact factor:   3.842


  11 in total

Review 1.  Adverse effects of sports supplements in men.

Authors:  Sarah J Martin; Miranda Sherley; Malcolm McLeod
Journal:  Aust Prescr       Date:  2018-02-01

Review 2.  Testosterone Replacement Therapy in Hypogonadal Men.

Authors:  Christina Wang; Ronald S Swerdloff
Journal:  Endocrinol Metab Clin North Am       Date:  2022-02-08       Impact factor: 4.741

3.  Anabolic steroids abuse and male infertility.

Authors:  Rabih El Osta; Thierry Almont; Catherine Diligent; Nicolas Hubert; Pascal Eschwège; Jacques Hubert
Journal:  Basic Clin Androl       Date:  2016-02-06

4.  Effect of testosterone boosters on body functions: Case report.

Authors:  Amer Abdulrahman Almaiman
Journal:  Int J Health Sci (Qassim)       Date:  2018 Mar-Apr

5.  Heterozygous Inactivation of the Nuclear Receptor PXR/NR1I2 in a Patient With Anabolic Steroid-Induced Intrahepatic Cholestasis.

Authors:  Roman Liebe; Marcin Krawczyk; Joanna Raszeja-Wyszomirska; Beata Kruk; Rebecca Preis; Jocelyn Trottier; Olivier Barbier; Piotr Milkiewicz; Frank Lammert
Journal:  Hepat Mon       Date:  2016-07-23       Impact factor: 0.660

Review 6.  Adverse Effects of Anabolic-Androgenic Steroids: A Literature Review.

Authors:  Giuseppe Davide Albano; Francesco Amico; Giuseppe Cocimano; Aldo Liberto; Francesca Maglietta; Massimiliano Esposito; Giuseppe Li Rosi; Nunzio Di Nunno; Monica Salerno; Angelo Montana
Journal:  Healthcare (Basel)       Date:  2021-01-19

Review 7.  Anabolic androgenic steroid-induced liver injury: An update.

Authors:  Ana Petrovic; Sonja Vukadin; Renata Sikora; Kristina Bojanic; Robert Smolic; Davor Plavec; George Y Wu; Martina Smolic
Journal:  World J Gastroenterol       Date:  2022-07-14       Impact factor: 5.374

Review 8.  Scientific and Regulatory Perspectives in Herbal and Dietary Supplement Associated Hepatotoxicity in the United States.

Authors:  Mark I Avigan; Robert P Mozersky; Leonard B Seeff
Journal:  Int J Mol Sci       Date:  2016-03-03       Impact factor: 5.923

Review 9.  Prohibited Contaminants in Dietary Supplements.

Authors:  Neilson M Mathews
Journal:  Sports Health       Date:  2017-08-29       Impact factor: 3.843

Review 10.  Designer drugs: mechanism of action and adverse effects.

Authors:  Dino Luethi; Matthias E Liechti
Journal:  Arch Toxicol       Date:  2020-04-06       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.